| Literature DB >> 32368642 |
N I Agbeboh1,2, I O Oladele1, O O Daramola1,3, A A Adediran4, O O Olasukanmi5, M O Tanimola6.
Abstract
Hard tissue regeneration and regrowth have continued to be a challenge in the field of conventional medicine in this 21st century. Over the years, the regrowth of broken bones and diseased hard tissue has remained a major concern in medical research. Since the discovery of hydroxyapatite (HA), a bioceramic compound that possesses the ability to activate bone regrowth and bond directly with regenerated bone, it has subsequently become an indispensable biomaterial. Currently, it is being used across the medical fields due to its exceptional biocompatibility. This became plausible because the main mineral phase of mammalian bones is HA. It has found application in various medical fields like medical instruments, drug delivery, bone and tooth fillers, prosthetics, orthotics, and in-vitro implants. As the importance of HA geometrically increases, it is necessary to critically evaluate and propose the most economic process of synthesizing and manufacturing this important bioceramic material. This review, therefore, highlights the different sources of HA and the synthesis/production methods for each source with a strong emphasis on the environment. Thus, the appraisal was carried out based on the properties of the derived HA. Such properties include but are not limited to geometry, particle size, morphology, thermal stability, and stoichiometry to suggest the most economic and environmentally sustainable sources and processing routes.Entities:
Keywords: Bioceramics; Biocomposites; Biomaterials; Biomedical engineering; Environmental impact assessment; Hard tissue regeneration; Hydroxyapatite; In-vitro implants; Materials chemistry; Materials science; Osteoinductive; Pollution control; Prosthesis
Year: 2020 PMID: 32368642 PMCID: PMC7184159 DOI: 10.1016/j.heliyon.2020.e03765
Source DB: PubMed Journal: Heliyon ISSN: 2405-8440
Common calcium phosphate compounds in the CaP spectrum and their applications (Akram et al., 2014).
| No. | Compound Name | Application | Chemical Formula | Crystal Structure | Ca/P Ratio |
|---|---|---|---|---|---|
| 1. | Monocalcium phosphate monohydrate | Enhances the uptake of root fluoride in the body ( | Ca(H2PO4)2.H2O | Triclinic | 0.5 |
| 2. | α-Tricalcium phosphate | Used in the repair of bones as a biodegradable composite ( | α-Ca3(PO4)2 | Monoclinic | 1.5 |
| 3. | β-Tricalcium phosphate | Used in orthopaedic surgery | β-Ca3(PO4)2 | Rhombohedral | 1.5 |
| 4. | Tetracalcium phosphate | Utilized in metallic implants as coatings, binders and cement | Ca4(PO4)2O | Monoclinic ( | 2 |
| 5. | Monocalcium phosphate (anhydrous) | It is used to form artificial bone grafts | Ca(H2PO4)2 | Triclinic | 0.5 |
| 6. | Dicalcium phosphate dihydrate | Used in the controlled release of drugs that are highly soluble in water ( | CaHPO4 2H2O | Monoclinic ( | 1 |
| 7. | Dicalcium phosphate anhydrous | It is used as a source of calcium and phosphorus in food supplements and also for polishing teeth | CaHPO4 | Orthorhombic ( | 1 |
| 8. | Hydroxyapatite | Used in the repair and regrowth of hard tissues | Ca10(PO4)6 (OH)2 | Hexagonal ( | 1.67 |
| 9. | Calcium-deficient hydroxyapatite | Used for bone grafting | Ca10-x (HPO4)x (PO4)6-x (OH)2-x | Hexagonal | 1.5–1.6 |
| 10. | Fluorapatite | Used in the making of pharmaceutical products as a source of flourine | Ca10(PO4)6F2 | Hexagonal ( | 1.67 |
Figure 1A phase diagram of the calcium phosphate system spectrum.
Synthetic Processes and Techniques for Producing HA Powders using Different Chemicals and Reactants (Nayak, 2010).
| S/N | Processing Technique | Reference/Source |
|---|---|---|
| 1. | Spray pyrolysis | |
| 2. | Sol gel technique | ( |
| 3. | Solution combustion | ( |
| 4. | Hydrolysis | ( |
| 5. | Microwave | ( |
| 6. | Solid state reaction | ( |
| 7. | Hydrothermal | ( |
| 8. | Emulsion method | ( |
| 9. | Mechanochemical | ( |
| 10. | Precipitation methods including: | ( |
A summary of the different procedures for the synthesization of HA.
| Methods | General remarks | Advantage | Disadvantage |
|---|---|---|---|
| Wet methods Precipitation ( | High crystallinity after sintering at 900 °C | Low cost | Diverse of HAp morphology |
Grain size increased with increasing sintering temperature. | Few number of chemicals | Low crystallinity of HAp | |
Grain size of 7.7–59.0 nm | Nano size of HAp | High crystallinity of HAp after sintering at high temperature | |
| Hydrolysis ( | The grain size decreased when synthesized with cetyltrimethylammonium. | Low temperature process | High cost |
Grain size of 20–50 nm | Few number of chemicals | Diverse of HAp morphology | |
Ca/P ratio: 1.33–1.67 | High phase purity of HAp | ||
Nano size of HAp | |||
| Emulsion ( | The crystallinity increased with increasing heat treatment temperature. | High phase purity of HAp | High cost |
The stability of the apatite phase achieved when being heat treated at 800 °C–1300 °C. | Many number of chemicals | ||
Particle size of 200–1300 μm | Non-stoichometric HAp | ||
Ca/P ratio: 1.5–1.2 | Low crystallinity of HAp | ||
| Hydrothermal ( | Rod-like morphology with hexagonal shape | High crystallinity of HAp | High cost |
Ca/P ratio: 1.67 | Stoichometric HAp | ||
| Sol-gel ( | Variation of Ca/P molar ratio depends on the calcinations temperature. | Nano size of HAp | Diverse of HAp morphology |
Crystalline size of 20–60 nm | High phase purity of HAp | ||
Ca/P ratio: 1.66–1.77 | |||
| Dry methods | The calcining temperatures were critical in controlling the size and shape of HAp particle. | Low cost | Low phase purity of HAp |
Particle size of 747–1510 nm | Few number of chemicals | High crystallinity of HAp after sintering at high temperature | |
Ca/P ratio: 1.67 | Micron size of HAp | ||
| Mechanochemical ( | Particle size decreased with increasing mechanical activation duration. | Easy production and room temperature process | Low phase purity of HAp |
Average particle size of ~25 nm | Low cost | Non-stoichiometric HAp | |
Nano size of HAp | High crystallinity of HAp after sintering at high temperature |
Figure 2Different sources of HA with their preparation and synthesis routes.
Figure 3Plant sources of Hydroxyapatite.
Figure 4Bovine bones (animal source of hydroxyapatite).
Figure 5XRD pattern of Synthesized HA.
Figure 6Snail shells (Biogenic Source of Hydroxyapatite).
A comparison of the mineral constituents of Hen and Crocodile Egg Shells (Mwambungu et al., 2014).
| Minerals | Hen Egg Shells (mg/100g) | Crocodile Egg Shells (mg/100g) |
|---|---|---|
| Copper | 0.93 ± 0.00 | 0.97 ± 0.02 |
| Cobalt | 0.93 ± 0.01 | 0.79 ± 0.06 |
| Manganese | 0.93 ± 0.01 | 0.79 ± 0.05 |
| Iron | 7.64 ± 0.02 | 7.23 ± 0.14 |
| Potassium | 82.2 ± 0.7 | 44.0 ± 0.6 |
| Sodium | 168.9 ± 0.3 | 151.2 ± 1.2 |
| Lead | 1.36 ± 0.1 | 2.5 ± 0.2 |
| Zinc | 0.93 ± 0.02 | 0.79 ± 0.05 |
| Chromium | 6.0 ± 0.3 | 6.3 ± 0.3 |
| Magnesium | 247.7 ± 0.3 | 110.0 ± 1.3 |
| Calcium | 2534.4 ± 10.6 | 2271.7 ± 8.8 |
| Phosphorus | 139.8 ± 0.2 | 5.0 ± 0.1 |